Laura Luberto

Rome, 00128, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

A Novel Lactobacillus brevis Fermented with a Vegetable Substrate (AL0035) Counteracts TNBS-Induced Colitis by Modulating the Gut Microbiota Composition and Intestinal Barrier.

A Novel Lactobacillus brevis Fermented with a Vegetable Substrate (AL0035) Counteracts TNBS-Induced Colitis by Modulating the Gut Microbiota Composition and Intestinal Barrier.

Journal: Nutrients
Published: February 07, 2024

Isolation and Characterization of Neutralizing Monoclonal Antibodies from a Large Panel of Murine Antibodies against RBD of the SARS-CoV-2 Spike Protein.

Isolation and Characterization of Neutralizing Monoclonal Antibodies from a Large Panel of Murine Antibodies against RBD of the SARS-CoV-2 Spike Protein.

Journal: Antibodies (Basel, Switzerland)
Published: November 15, 2023

Spike mutation resilient scFv76 antibody counteracts SARS-CoV-2 lung damage upon aerosol delivery.

Spike mutation resilient scFv76 antibody counteracts SARS-CoV-2 lung damage upon aerosol delivery.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: June 28, 2022

Human inhalable antibody fragments neutralizing SARS-CoV-2 variants for COVID-19 therapy.

Human inhalable antibody fragments neutralizing SARS-CoV-2 variants for COVID-19 therapy.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: November 29, 2021

Genetic Vaccination as a Flexible Tool to Overcome the Immunological Complexity of Invasive Fungal Infections.

Genetic Vaccination as a Flexible Tool to Overcome the Immunological Complexity of Invasive Fungal Infections.

Journal: Frontiers in microbiology
Published: October 05, 2021

Toxicity and Local Tolerance of COVID- eVax, a Plasmid DNA Vaccine for SARS-CoV-2, Delivered by Electroporation.

Toxicity and Local Tolerance of COVID- eVax, a Plasmid DNA Vaccine for SARS-CoV-2, Delivered by Electroporation.

Journal: Toxicologic pathology
Published: September 08, 2021

COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models.

COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: July 01, 2021

SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines.

SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines.

Journal: Journal of translational medicine
Published: April 22, 2020

Poly-specific neoantigen-targeted cancer vaccines delay patient derived tumor growth.

Poly-specific neoantigen-targeted cancer vaccines delay patient derived tumor growth.

Journal: Journal of experimental & clinical cancer research : CR
Published: December 18, 2018

Intra-tumor AvidinOX allows efficacy of low dose systemic biotinylated Cetuximab in a model of head and neck cancer.

Intra-tumor AvidinOX allows efficacy of low dose systemic biotinylated Cetuximab in a model of head and neck cancer.

Journal: Oncotarget
Published: July 07, 2015

Superior Immunologic and Therapeutic Efficacy of a Xenogeneic Genetic Cancer Vaccine Targeting Carcinoembryonic Human Antigen.

Superior Immunologic and Therapeutic Efficacy of a Xenogeneic Genetic Cancer Vaccine Targeting Carcinoembryonic Human Antigen.

Journal: Human gene therapy
Published: April 15, 2015

Safety and efficacy of a genetic vaccine targeting telomerase plus chemotherapy for the therapy of canine B-cell lymphoma.

Safety and efficacy of a genetic vaccine targeting telomerase plus chemotherapy for the therapy of canine B-cell lymphoma.

Journal: Human gene therapy
Published: August 02, 2013
Showing 1-12 of 14

Last Updated: 09/26/2026